By Pushkala Aripaka (Reuters) -Sensodyne toothpaste maker Haleon on Thursday forecast high single-digit percentage growth in ...

(Reuters) -Haleon on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets ...

Haleon PLC HLN shares advanced 3.27% to £3.89 Thursday, on what proved to be an all-around positive trading session for the ...

British consumer healthcare group Haleon on Wednesday reported a 2.3% fall in its first-quarter revenue as sluggish demand ...

Pavan Wani, Category Lead - Pain & Respiratory, Haleon ISC speaks on enduring success of its legacy brands, importance of ...

Global player in consumer health Haleon and Brightseed, experts in the AI-driven discovery of bioactive compounds, have joined forces to advance the discovery of plant-based, small molecules that can ...

Brightseed's AI-driven approach to bioactive discovery has already yielded key insights into plant compounds with potential applications across metabolic health, gut health, immunity, and more. This ...

British consumer healthcare group Haleon highlighted an uncertain demand outlook, particularly in the United States.

The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...

Find insight on Haleon, GSK and more in the latest Market Talks covering the health care sector.

30 April 2025: Haleon plc (the "Company" or "Haleon") today announces its Q1 trading statement for the year ending 31 December 2025 is available at: http://www.rns ...

Brightseed has teamed up with Haleon to advance the discovery of plant-based small molecules with potential health benefits.